
|Articles|November 1, 2003
Single-dose Equivalency Seen
New York - California researchers have challenged the widespread belief among dermatologists that a "triple-dose" methotrexate regimen - in which three small doses of the potent drug are administered in 12-hour intervals -causes less liver toxicity than one large dose given once weekly.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
2
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
3
Oral STAT6 Degrader KT-621 Shows Biologic-Comparable Activity in Atopic Dermatitis
4
Moving Past Dermal Filler Trends to Focus on Healthy Skin Aging
5














